The Cochrane Breast Cancer Group is committed to the development of evidence relating to the prevention, early detection and treatment of breast cancer.
The group was registered as a Collaborative Review Group with The Cochrane Collaboration in September 1996. Its activities are coordinated by an international team of editors and an editorial base located at the NHMRC Clinical Trials Centre, The University of Sydney, Australia.
The Cochrane Breast Cancer Group would like to acknowledge its current supporters:
National Health and Medical Research Council (NHMRC), Australia
NHMRC Clinical Trials Centre, University of Sydney
and past supporters:
Commonwealth Department of Health and Ageing
US Department of Defense
Australian New Zealand Breast Cancer Trials Group
Breast Cancer Institute of Australia
*Authors please note the publication deadlines relevant to protocols and reviews for 2013 are available*